Vijaypd ceutical limited IPO Overview
Vijaypd ceutical limited IPO is a SME public issue offered through a Fixed Price issue with a total issue size of ₹19.25 Cr. The IPO price band is set at ₹35 per share, and retail investors can apply with a minimum investment of ₹2.80 L as per IPO guidelines.
The Vijaypd ceutical limited IPO opens on 29 Sept 2025 and closes on 1 Oct 2025. The IPO allotment is expected to be finalized on 3 Oct 2025, and the equity shares are proposed to be listed on NSE on 7 Oct 2025.
Investors can refer to the Vijaypd ceutical limited IPO RHP-DRHP for detailed information. The issue is managed by Smart Horizon Capital Advisors Pvt.Ltd. as the book running lead manager, while Kfin Technologies Limited is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About vijaypd ceutical limited
The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers.
The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs.
As of Marc 31, 2025, the company serves over r 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations.
The company's distribution network connects with over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs.
This product portfolio allows the company to meet customer needs while ensuring quality and reliability in pharmaceutical supply.
The company is a pharmaceutical distributor with FDA, FSSAI, and BMC certifications.
Competitive Strength:
Strengthen its market position by increasing its long-term relationships with its clients.
Comprehensive product portfolio.
Streamlined supply chain management.
Experienced management team with proven execution capabilities.
Investment Objective
Repayment/prepayment of all or certain of the borrowings availed of by the Company
General corporate purposes